Join G2 Intelligence for this interactive discussion about whether clinical immunohistochemistry testing should be a stain or an assay, with our experts offering arguments for and against the proposed changes
Join us and our experts to learn how labs can reimagine infrastructure utilization through collaboration to improve health system finances and enrich their value proposition
Research reveals that diagnostic error in the US may cause up to 800,000 serious outcomes annually.
A research team has developed a new, simpler microfluidic chip that could make at-home diagnosis of diseases faster and more affordable
